The antileukemic effect of NK and NK-T cells against chronic myelogenous leukemia is dominated by interactions between activating molecules and their ligands which overcome inhibitory KIR-MHC class I interaction.

被引：0
|
作者：
Sconocchia, G
Lau, M
Provenzano, M
Rezvani, K
Fujiwara, H
Ferrone, S
Barrett, J
机构：
[1] NHLBI, Hematol Branch, Bethesda, MD 20892 USA
[2] NIH, Dept Transfus Med, Bethesda, MD 20892 USA
[3] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2948
引用
收藏
页码：806A / 806A
页数：1
相关论文
共 3 条
  • [1] The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions
    Sconocchia, G
    Lau, M
    Provenzano, M
    Rezvani, K
    Wongsena, W
    Fujiwara, H
    Hensel, N
    Melenhorst, J
    Li, JM
    Ferrone, S
    Barrett, AJ
    BLOOD, 2005, 106 (10) : 3666 - 3672
  • [2] Killer cell inhibitory receptor (KIR) for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, γδ T cells, and antigen-specific CTL
    Bakker, ABH
    Phillips, JH
    Figdor, CG
    Lanier, LL
    FASEB JOURNAL, 1998, 12 (04): : A288 - A288
  • [3] Killer immunoglobulin receptor (KIR) negative NK cells exhibit potent alloreactivity against primary leukemia targets when interrupting MHC class I interactions through NKG2A blockade
    Godal, Robert
    Gleason, Michelle
    McCullar, Valarie
    Cooley, Sarah
    Vemeris, Michael
    McGlave, Philip
    Miller, Jeffrey S.
    BLOOD, 2007, 110 (11) : 842A - 842A
1